ARCHIVE

• The 109th Annual Meeting of Japan Ophthalmological Society
  April 18, 2005

• Kibanken Starts Up with Staff of 95
  April 18, 2005

• Kyoto Univ. Hospital to Beef Up New Drug Development
  April 18, 2005

• Huma Aims to Boost Registered Volunteers to 500,000
  April 18, 2005

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  April 18, 2005

• Roche's Anticancer Agent Tarceva Approved in Switzerland
  April 11, 2005

• Amended PAL Goes into Full Effect
  April 11, 2005

• Self-injection to Be Allowed for INF a, Etanercept
  April 11, 2005

• DIAGNOSTIC NEWS IN BRIEF
  April 11, 2005

• Council for Unapproved Drugs Examines Natalizumab, Bortezumib
  April 11, 2005

• Chuikyo Approves Listing of 3 Drugs Including Oxaliplatin
  April 11, 2005

• Study Group on Clinical Trials Holds 1st Meeting
  April 11, 2005

• MREAC Finalizes Activities Plan for FY2005
  April 11, 2005

• Pfizer Japan Maintains Lead in MR Calls: MOSS Institute
  April 11, 2005

• Rules on Sale of Ethical Drugs Clarified
  April 11, 2005

• 1st 3Qtrs Business Results
  April 11, 2005

• PMDA to Answer Complaints within 15 Days
  April 11, 2005

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  April 11, 2005

• REGULATORY NEWS IN BRIEF
  April 11, 2005

• The Reporter's Eye: 4
  April 11, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 471
• 472
• 473
• 474
• 475
• 476
• 477
• 478
• 479
• …
• Next ›
• 最終 »